FDA Approves J&J, Bayer’s Xarelto for Stroke Prevention
The FDA has approved a stroke prevention indication for Johnson & Johnson (J&J) and Bayer’s blood thinner Xarelto in atrial fibrillation (AF) patients despite an outpouring of concern about the drug’s safety and efficacy.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.